EFX vs NDRA · P/E 54, rev $5.68B vs P/E 0.0, $2.6M cap
Equifax Inc (EFX) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
NDRA does not have a complete income-statement cache yet.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the EFX and NDRA stock pages for the full models.
Not investment advice.